EMJ Podcast: Insights For Healthcare Professionals

In this episode of Hema Now, Pieter Sonneveld, Chair of the European Myeloma Network (EMN) and a leading voice in haematology, discusses how research and collaborative trials, like PERSEUS and CEPHEUS, are redefining standards of care in multiple myeloma. From the importance of early diagnosis to the evolving role of minimal residual disease testing, this conversation offers a forward-looking perspective on what's next for patients and clinicians alike.

Timestamps

00:00 – Introduction

01:36 – Initial interest in multiple myeloma

03:24 – Treatment landscape

05:25 – Minimal residual disease

08:20 – European Myeloma Network (EMN)

11:04 – Overview of the PERSEUS trial

14:37 – Overview of the CEPHEUS trial

17:45 – The future of myeloma care

20:38 – Pieter's three wishes for healthcare

Holly Wyatt explores the psychological side of sustained weight loss: mindset, identity shifts, and why willpower isn't enough. Discover patterns from over 10,000 successful weight maintainers, and the first steps toward emotional resilience in obesity care.

Timestamps:

00:45 – Wyatt's Journey

03:48 – Psychological barriers

06:09 – State of Slim

08:06 – Successful losers

11:16 – Advice

In this rapid-fire episode, Holly Wyatt answers key questions on metabolism, myths, motivation, GLP-1 misconceptions, and daily health habits. Ideal for listeners seeking a fast, insightful overview of modern weight management in under 5 minutes.

This content was funded by Boehringer Ingelheim, who had no influence or involvement in the development of the content. This material is intended for U.S. healthcare professionals.

Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood. In this AMJ podcast, Ayodeji Adegunsoye and Toby Maher share their expert perspectives on how the field is changing, how recent data are shaping clinical decision-making, and why holistic, patient-centered care is critical.

Chapters:

1. 03:02 – 15:34 – A Decade Without New Options
2. 15:34 – 27:47 – Understanding the Latest Clinical Trial Data
3. 27:47 – 39:28 – From Hesitancy to Action: Reaching the Community Clinician
4. 39:28 – 54:10 – Psychosocial Support and Patient-Centered Care
5. 54:10 – 01:02:07 – The Role of Primary Care in ILD Diagnosis
6. 01:02:07 – 1:07:48 – Call to Action

Speakers:

• Ayodeji Adegunsoye, MD, PhD – Assistant Professor of Medicine, Biological Sciences Division, University of Chicago, Illinois, USA
• Toby Maher, MD, PhD – Professor of Clinical Medicine, Keck School of Medicine, University of Southern California, USA

In the final episode of this series, Susanna Esposito explores how vaccine coverage, microbiome preservation, and emerging therapeutics intersect with antimicrobial stewardship. She also discusses innovative strategies, such as bacteriophages, microbiome-targeted therapies, and AI-driven predictive analytics, to prevent infections while optimising antibiotic use in children.

Timestamps:

00:00 – Introduction

00:50 – Vaccine coverage

02:20 – Gut–lung axis

03:23 – Microbiome-targeted therapies

04:37 – Bacteriophages

05:45 – AI analytics

06:30 – Final message

In the second deep dive of the series, Susanna Esposito discusses the latest guidelines for diagnosing and treating bacterial meningitis in children. She highlights balancing urgent empirical therapy with stewardship principles, appropriate use of corticosteroids, emerging resistance patterns, and how hospitals can leverage local data to optimise antibiotic prescribing.

Timestamps:

00:00 – Introduction

00:53 – Tackling meningitis

02:42 – Corticosteroid use

03:37 – Access, Watch, and Reserve (AWaRe) classification

05:49 – Resistance patterns

06:51 – Point prevalence surveys